基于结构的发现Obeticol酸衍生物作为新型Farnesoid X受体部分激动剂,具有改善的选择性和减少的非目标效应
Daniela Passeri1, Bruno Cerra2, Andrea Carotti2
1Tes Pharma, S.r.l., Via Giovine Italia 1, 06073, Solomeo (PG), Italy.
ChemMedChem
|February 4, 2026
概括
新的obeticholic酸衍生物被开发为更安全的Farnesoid X受体 (FXR) 调节器. 这些化合物表现出效率降低,并避免激活MRGPRX4受体,从而有可能在代谢和肝脏疾病治疗中最大限度地减少等副作用.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 法内索伊德X受体 (FXR) 是肠肝和代谢疾病的关键治疗点.
- 寻求FXR部分激动剂来减轻过度激活的副作用.
- 肥酸 (OCA) 是一种FXR激活剂,具有潜在的副作用,包括.
研究的目的:
- 设计,合成和评估新型肥酸 (OCA) 衍生物作为选择性FXR调节剂.
- 确定具有降低激动剂疗效和改进安全配置文件的FXR调节器.
- 为了研究管理FXR部分激励和非目标效应的结构-活动关系.
主要方法:
- 合成具有C3α位置和侧链结构修饰的新型OCA衍生物.
- 对FXR调制的生物评估,包括激动剂疗效和受体激活试验.
- 分子动力学模拟用于分析FXR联体结合域中联体诱导的构造变化.
- 评估非目标活性,特别是MRGPRX4 (hX4) 受体上的活动.
主要成果:
- 瓦林衍生物2和16被确定为代谢稳定和安全的FXR调节剂,具有降低的激素效率.
- 分子动力学模拟显示了FXR中明显的形状变化,与部分激进相一致.
- 化合物2和16没有激活MRGPRX4 (hX4) 受体,与OCA.不同.
- 在新型衍生品中观察到FXR目标基因的适度调节.
结论:
- 新型OCA衍生品显示出作为更安全的FXR调节器的潜力,降低了风险.
- 了解结构-活性关系对于开发具有更高安全性的FXR疗法至关重要.
- 这些化合物作为有价值的化学工具,用于推进针对肝脏和代谢障碍的FXR向疗法.
相关概念视频
Structures of Carboxylic Acid Derivatives
3.8K
Structure of Carboxylic Acid Derivatives
Carboxylic acid derivatives contain an acyl group attached to a heteroatom such as chlorine, oxygen, or nitrogen. The carbonyl carbon and oxygen are both sp2-hybridized with an unhybridized p orbital.
The three sp2 orbitals of the carbonyl carbon form three σ bonds, one each with the carbonyl oxygen, the α carbon, and the heteroatom, whereas the other two sp2 orbitals of the carbonyl oxygen are occupied by the lone pairs. Further, the unhybridized p...
Carboxylic acid derivatives contain an acyl group attached to a heteroatom such as chlorine, oxygen, or nitrogen. The carbonyl carbon and oxygen are both sp2-hybridized with an unhybridized p orbital.
The three sp2 orbitals of the carbonyl carbon form three σ bonds, one each with the carbonyl oxygen, the α carbon, and the heteroatom, whereas the other two sp2 orbitals of the carbonyl oxygen are occupied by the lone pairs. Further, the unhybridized p...
3.8K
Glucagon-like Receptor Agonists
980
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
980
Drug-Receptor Interaction: Agonist
4.1K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.1K
Acid Strength and Molecular Structure
33.1K
Binary Acids and Bases
In the absence of any leveling effect, the acid strength of binary compounds of hydrogen with nonmetals (A) increases as the H-A bond strength decreases down a group in the periodic table. For group 17, the order of increasing acidity is HF < HCl < HBr < HI. Likewise, for group 16, the order of increasing acid strength is H2O < H2S < H2Se < H2Te. Across a row in the periodic table, the acid strength of binary hydrogen compounds increases with increasing...
In the absence of any leveling effect, the acid strength of binary compounds of hydrogen with nonmetals (A) increases as the H-A bond strength decreases down a group in the periodic table. For group 17, the order of increasing acidity is HF < HCl < HBr < HI. Likewise, for group 16, the order of increasing acid strength is H2O < H2S < H2Se < H2Te. Across a row in the periodic table, the acid strength of binary hydrogen compounds increases with increasing...
33.1K
Bronsted-Lowry Acids and Bases
105.4K
The acid-base reaction class has been studied for quite some time. In 1680, Robert Boyle reported traits of acid solutions that included their ability to dissolve many substances, to change the colors of certain natural dyes, and to lose these traits after coming in contact with alkali (base) solutions. In the eighteenth century, it was recognized that acids have a sour taste, react with limestone to liberate a gaseous substance (now known to be CO2), and interact with alkalis to form neutral...
105.4K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
1.0K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.0K


